LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
138,600
+2,900 (2.14%)
Aug 5, 2025, 3:30 PM KST
2.14%
Market Cap5.02T
Revenue (ttm)146.42B
Net Income (ttm)24.86B
Shares Out36.25M
EPS (ttm)671.86
PE Ratio206.29
Forward PE97.17
Dividendn/a
Ex-Dividend Daten/a
Volume363,014
Average Volume572,358
Open139,800
Previous Close135,700
Day's Range137,300 - 142,000
52-Week Range66,900 - 156,200
Beta0.77
RSI56.24
Earnings DateAug 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.